Agenerase mindskede også virusind - holdet hos børn, selvom meget få af de børn, der tidligere havde fået proteasehæmmere, responderede på behandlingen.
Agenerase also reduced viral loads in children, although very few of the children who had taken protease inhibitors in the past responded to treatment.